Cambridge Innovation Capital
CIC backs life sciences and technology companies in Europe’s leading ecosystem, Cambridge. A preferred investor for the university.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Cambridge Innovation Capital Information
Geographic Data
Address: 22 Station Road
City: Cambridge
State: england
Zip: CB1 2JD
Country: GB
Financial Info
Stage:
Raised Last:
$0
Raised Total:$75M
Social
Twitter
Linkedin
Crunchbase
Metrics
5,598,936Website Global Rank
1,677Website Monthly Traffic
Twitter Followers
Description
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. Since our inception in 2013, we have raised £275 million to invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2023 | Mosaic Therapeutics | Series A | 28M |
| 11/2022 | Cambridge GaN Devices | Series B | 0 |
| 5/2017 | Z Factor | Series A | 9M |
| 9/2021 | PetMedix | Series B | 37.2M |
| 1/2016 | Inivata | Series A | 45.2M |
| 5/2022 | Salience Labs | Seed Round | 11.5M |
| 11/2020 | Congenica | Series C | 50M |
| 12/2017 | Cytora | Series A | 5.9M |
| 10/2016 | Pragmatic Semiconductor | Venture Round | 22M |
| 9/2017 | CMR Surgical | Series A | 0 |
| 9/2018 | AudioTelligence | Seed Round | 4M |
| 1/2016 | Morphogen-IX | Series A | 2.1M |
| 7/2016 | CMR Surgical | Series A | 0 |
| 6/2015 | Storm Therapeutics | Seed Round | - |
| 9/2022 | Unlikely AI | Seed Round | 20.3M |
| 9/2017 | Secondmind | Series A | 13M |
| 6/2018 | CMR Surgical | Series B | 0 |
| 6/2021 | CMR Surgical | Series D | 0 |
| 9/2019 | CMR Surgical | Series C | 0 |
| 5/2015 | Abcodia | Series B | 8.2M |
| 6/2019 | Riverlane | Seed Round | 4.1M |
| 6/2016 | Storm Therapeutics | Series A | 16M |
| 6/2017 | Bicycle Therapeutics | Series B | 52M |
| 3/2021 | Gyroscope Therapeutics | Series C | 0 |
| 12/2015 | Jukedeck | Venture Round | 3M |
| 4/2018 | Origami | Series B | 0 |
| 9/2022 | Pretzel Therapeutics | Series A | 0 |
| 4/2023 | Riverlane | Series B | 0 |
| 6/2021 | Origami | Series C | 0 |
| 3/2020 | AudioTelligence | Series A | 8.5M |
| 12/2014 | Congenica | Venture Round | 1.6M |
| 12/2022 | Carrick Therapeutics | Series C | 0 |
| 5/2014 | Imagen | Series A | 2.5M |
| 1/2019 | Imagen | Series B | 8.4M |
| 10/2016 | Undo Ltd. | Series A | 3.3M |
| 7/2018 | Swim | Series B | 0 |
| 1/2017 | Audio Analytic | Series A | 5.5M |
| 12/2018 | Morphogen-IX | Series B | 23.3M |
| 9/2014 | Origami | Venture Round | 5.8M |
| 9/2014 | Inivata | Venture Round | 6.6M |
| 9/2014 | Jukedeck | Seed Round | 830.5k |
| 2/2019 | Pragmatic Semiconductor | Venture Round | 17M |
| 12/2016 | Microbiotica | Seed Round | 9.9M |
| 5/2015 | Imagen | Series A | 3.1M |
| 11/2016 | Imagen | Venture Round | 3.1M |
| 1/2017 | Exvastat | Seed Round | - |
| 12/2020 | Secondmind | Corporate Round | 11.7M |
| 2/2019 | PragmatIC Semiconductor | Venture Round | 17M |
| 4/2015 | Congenica | Series A | 3.3M |
| 4/2021 | Sense Biodetection | Series B | 50M |
| 4/2019 | Cytora | Series B | 32.6M |
| 5/2019 | Secondmind | Series B | 24M |
| 10/2016 | PragmatIC Semiconductor | Venture Round | 22M |
| 4/2019 | PolyProx | Seed Round | 4.4M |
| 4/2015 | Undo | Seed Round | 2M |
| 10/2016 | Carrick Therapeutics | Series A | 95M |
| 12/2018 | Bicycle Therapeutics | Series B | 27.9M |
| 1/2015 | Pragmatic Semiconductor | Venture Round | 8.1M |
| 10/2021 | Pretzel Therapeutics | Venture Round | - |
| 4/2023 | Complement Therapeutics | Series A | 0 |
| 1/2015 | PragmatIC Semiconductor | Venture Round | 8.1M |
| 2/2022 | Microbiotica | Series B | 0 |
| 10/2019 | Sense Biodetection | Series A | 13.5M |
| 3/2023 | Seldon | Series B | 0 |
| 11/2020 | Seldon | Series A | 9.4M |
| 9/2018 | CEDAR Audio | Seed Round | 4M |
| 2/2016 | Audio Analytic | Venture Round | 1.1M |
| 7/2018 | Undo Ltd. | Series B | 14M |
| 1/2021 | Riverlane | Series A | 20M |
| 3/2019 | Inivata | Series B | 0 |
| 2/2018 | GeoSpock | Series A | 6.6M |
| 5/2019 | Storm Therapeutics | Series A | 17.8M |
| 9/2016 | Fluidic Analytics | Series B | 7.1M |
| 9/2019 | Gyroscope Therapeutics | Series B | 60.9M |
| 6/2019 | Audio Analytic | Series B | 12M |
| 12/2022 | Storm Therapeutics | Series B | 30M |
| 4/2016 | Origami | Series A | 19.4M |
| 10/2015 | GeoSpock | Series A | 5.4M |
| 10/2020 | GeoSpock | Venture Round | 0 |
| 4/2022 | Epitopea | Seed Round | 0 |
| 9/2016 | PervasID | Series A | 933.6k |
| 2/2017 | Congenica | Series B | 10M |
| 7/2019 | PredictImmune | Series B | 12.3M |
| 5/2022 | Salience Labs | Seed Round | 0 |
| 4/2022 | Epitopea | Seed Round | 0 |
| 2/2022 | Microbiotica | Series B | 0 |
| 10/2021 | Pretzel Therapeutics | Venture Round | - |
| 9/2021 | PetMedix | Series B | 0 |
| 6/2021 | CMR Surgical | Series D | 0 |
| 6/2021 | Origami | Series C | 0 |
| 4/2021 | Sense Biodetection | Series B | 0 |
| 3/2021 | Gyroscope Therapeutics | Series C | 0 |
| 1/2021 | Riverlane | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
